Superales, Baby Girl .

HRN: 23-89-91  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2023
AMPICILLIN 250MG (VIAL)
10/27/2023
11/03/2023
IV
130mg
Q12
Potentially Septic Newborn (Thickly Msaf)
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: